 | • レポートコード：MRC2304A039 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、228ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、2021年に1,727.24百万ドルであった世界の補助人工心臓（VAD）市場規模が2022年に1,831.08百万ドルへと拡大、更に2027年までにCAGR 6.18％で成長して2,476.42百万ドルに達すると予測しています。当書は、補助人工心臓（VAD）の世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（両室補助人工心臓、左室補助人工心臓、右室補助人工心臓、全人工心臓）、フロータイプ別分析（連続流型、拍動流型）、デザイン別分析（植込み型、経皮型）、用途別分析（移植橋渡し（BTT）、DT治療）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの構成でまとめています。なお、当書には、Abbott Laboratories Ltd、ABIOMED Inc、Asahi Kasei Corporation、Berlin Heart GmbH、Boston Scientific Corporation、Calon Cardio-Technology Ltd.、Cardinal Health, Inc.、CorWave SA、Jarvik Heart, Inc.、Koninklijke Philips N.V.、Medtronic PLCなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の補助人工心臓（VAD）市場規模：製品別 - 両室補助人工心臓の市場規模 - 左室補助人工心臓の市場規模 - 右室補助人工心臓の市場規模 - 全人工心臓の市場規模 ・世界の補助人工心臓（VAD）市場規模：フロータイプ別 - 連続流型補助人工心臓の市場規模 - 拍動流型補助人工心臓の市場規模 ・世界の補助人工心臓（VAD）市場規模：デザイン別 - 植込み型補助人工心臓の市場規模 - 経皮型補助人工心臓の市場規模 ・世界の補助人工心臓（VAD）市場規模：用途別 - 移植橋渡し（BTT）における市場規模 - DT治療における市場規模 ・世界の補助人工心臓（VAD）市場規模：地域別 - 南北アメリカの補助人工心臓（VAD）市場規模 アメリカの補助人工心臓（VAD）市場規模 カナダの補助人工心臓（VAD）市場規模 ブラジルの補助人工心臓（VAD）市場規模 ... - アジア太平洋の補助人工心臓（VAD）市場規模 日本の補助人工心臓（VAD）市場規模 中国の補助人工心臓（VAD）市場規模 インドの補助人工心臓（VAD）市場規模 韓国の補助人工心臓（VAD）市場規模 台湾の補助人工心臓（VAD）市場規模 ... - ヨーロッパ/中東/アフリカの補助人工心臓（VAD）市場規模 イギリスの補助人工心臓（VAD）市場規模 ドイツの補助人工心臓（VAD）市場規模 フランスの補助人工心臓（VAD）市場規模 ロシアの補助人工心臓（VAD）市場規模 ... - その他地域の補助人工心臓（VAD）市場規模 ・競争状況 ・企業情報 |
The Global Ventricular Assist Device Market size was estimated at USD 1,727.24 million in 2021 and expected to reach USD 1,831.08 million in 2022, and is projected to grow at a CAGR 6.18% to reach USD 2,476.42 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Ventricular Assist Device to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Biventricular Assist Device, Left Ventricular Assist Device, Right Ventricular Assist Device, and Total Artificial Heart.
Based on Type Of Flow Outlook, the market was studied across Continuous Flow and Pulsatile Flow.
Based on Design, the market was studied across Implantable Ventricular Assist Device and Transcutaneous Ventricular Assist Device.
Based on Application, the market was studied across Bridge to Transplant and Destination Therapy.
Based on End-User, the market was studied across Ambulatory Surgery Centers and Hospital.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Ventricular Assist Device market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ventricular Assist Device Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Ventricular Assist Device Market, including Abbott Laboratories Ltd, ABIOMED Inc, Asahi Kasei Corporation, Berlin Heart GmbH, Boston Scientific Corporation, Calon Cardio-Technology Ltd., Cardinal Health, Inc., CorWave SA, Jarvik Heart, Inc., Koninklijke Philips N.V., Medtronic PLC, Merck KGaA, Novartis AG, Sanofi SA, Stryker Corporation, SynCardia Systems, LLC, Teijin Pharma Limited, Terumo Medical Corporation, Transonic Systems Inc., and Veol Medical Technologies Pvt. Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Ventricular Assist Device Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ventricular Assist Device Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ventricular Assist Device Market?
4. What is the competitive strategic window for opportunities in the Global Ventricular Assist Device Market?
5. What are the technology trends and regulatory frameworks in the Global Ventricular Assist Device Market?
6. What is the market share of the leading vendors in the Global Ventricular Assist Device Market?
7. What modes and strategic moves are considered suitable for entering the Global Ventricular Assist Device Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of patients with heart failure
5.1.1.2. Shortage of transplant organs
5.1.1.3. Significant number of ongoing clinical trials focusing on ventricular assist devices
5.1.2. Restraints
5.1.2.1. High cost of the device and procedures
5.1.3. Opportunities
5.1.3.1. Technological advancements and development of miniature devices designed with advanced features
5.1.3.2. Increasing initiatives and awareness regarding cardiovascular diseases
5.1.3.3. Advances in surgical and medical management
5.1.4. Challenges
5.1.4.1. Stringent regulatory approvals
5.2. Cumulative Impact of COVID-19
6. Ventricular Assist Device Market, by Product
6.1. Introduction
6.2. Biventricular Assist Device
6.3. Left Ventricular Assist Device
6.4. Right Ventricular Assist Device
6.5. Total Artificial Heart
7. Ventricular Assist Device Market, by Type Of Flow Outlook
7.1. Introduction
7.2. Continuous Flow
7.3. Pulsatile Flow
8. Ventricular Assist Device Market, by Design
8.1. Introduction
8.2. Implantable Ventricular Assist Device
8.3. Transcutaneous Ventricular Assist Device
9. Ventricular Assist Device Market, by Application
9.1. Introduction
9.2. Bridge to Transplant
9.3. Destination Therapy
10. Ventricular Assist Device Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Hospital
11. Americas Ventricular Assist Device Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Ventricular Assist Device Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Ventricular Assist Device Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abbott Laboratories Ltd
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. ABIOMED Inc
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Asahi Kasei Corporation
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Berlin Heart GmbH
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Boston Scientific Corporation
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Calon Cardio-Technology Ltd.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Cardinal Health, Inc.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. CorWave SA
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Jarvik Heart, Inc.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Koninklijke Philips N.V.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Medtronic PLC
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Merck KGaA
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Novartis AG
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Sanofi SA
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Stryker Corporation
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. SynCardia Systems, LLC
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Teijin Pharma Limited
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Terumo Medical Corporation
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Transonic Systems Inc.
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Veol Medical Technologies Pvt. Ltd.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing